Stocktoria
Chemours Co CC
NYSE · XNYS · stock · Chemicals & Allied Products · website · IPO 2015-06-19
Chemours Co statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 15.5% | 19.8% | 21.4% | 23.7% | 21.8% |
| Net margin | -6.6% | 1.2% | -4.2% | 8.5% | 9.6% |
| FCF margin | 0.9% | -17.2% | 3.1% | 6.6% | 8.5% |
| Return on assets | -5.2% | 0.9% | -3.1% | 7.6% | 8.1% |
| Return on equity | -153.8% | 12.1% | -35.0% | 52.2% | 56.2% |
| Debt / equity | 16.33× | 7.10× | 5.52× | 3.24× | 3.44× |
| Current ratio | 1.78 | 1.66 | 1.55 | 1.70 | 1.80 |
| Revenue growth | 0.4% | -4.9% | -11.0% | 7.7% | 27.7% |
Source: SEC EDGAR filings · CIK 0001627223 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.